Chidamide decreases c-MET mRNA methylation and in turn increases the sensitivity of non-small cell lung cancer to crizotinib
N. Ding, A. You, W. Tian, L. Gu, D. Deng
This study shows chidamide reduces c-MET mRNA methylation, increasing NSCLC sensitivity to crizotinib, particularly in cells with high c-MET expression.
bioRxiv · Mar 28, 2020Pharmacology & Toxicology